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Treatment of bipolar depression during pregnancy remains
a clinical challenge due to the teratogenic risks of mood
stabilizers and, to a lesser extent, the risks associated
with antidepressants.1 However, if left untreated, there is
a significantly higher chance of maternal disease relapse
and morbidity.2 Repetitive transcranial magnetic stimula-
tion (rTMS), currently approved in the United States for
treatment of unipolar depression, has shown initial effi-
cacy for both bipolar depression and peripartum unipolar
depression.3,4 However, there is no known precedent of
its use for the treatment of peripartum bipolar depression.
We report the case of a patient with bipolar II disorder who
received rTMS for depression during the second and third
trimesters of pregnancy.
A 32-year-old G2P1 woman with a history of bipolar II
disorder presented at 20 weeks gestation due to peri-
partum recurrence of depressive symptoms. The patient
had a history of predominantly depressive episodes start-
ing from her early 20s, as well as two past suicide
attempts via pill overdose and one psychiatric hospitaliza-
tion for depression with suicidal ideations. She also expe-
rienced hypomanic episodes later on, characterized by
both irritable and expansive moods, with increased energy,
decreased need for sleep, distractibility, as well as shop-
ping and spending sprees. These periods lasted a maxi-
mum of 5 days, and never resulted in severe functional
impairment nor hospitalization. The patient had no history
of manic episodes, substance use, personality disorders,
any other psychiatric disorders, or medical comorbidities.
She had a family history of unipolar depression, but no
known history of suicide, bipolar disorder, or other psy-
chiatric illnesses.
The patient was intolerant to multiple antidepressants,
including paroxetine, venlafaxine, and bupropion; a trial of
escitalopram had been unsuccessful. These antidepres-
sant trials had never resulted in mixed depressive symp-
tomatology or switch into hypomania. Notably, she had
never received electroconvulsive therapy (ECT), due to
self-preference. The patient had previously undergone
three successful adjunctive courses of rTMS, with the last
course completed a year and a half before presentation.
She was on a regimen of lamotrigine 400 mg/day and
aripiprazole 15 mg/day for the past year, which was
continued throughout her treatment. She had recently
completed an intensive outpatient program for depres-
sion, but did not continue any psychotherapy during her
treatment.
On initial evaluation, the patient reported symptoms of
moderately depressed mood, decreased appetite with
weight loss, anergia, psychomotor retardation, and occa-
sional passive suicidal ideations without intent or plan.
With the exception of mildly slowed psychomotor activity
and a dysthymic affect, her mental status exam was
unremarkable. There was no evidence of psychosis or
a mixed manic episode. Given the patient’s previous
good response to rTMS and antidepressant intolerance,
a course of rTMS was initiated. She received fast-
frequency (10 Hz), 4-second train duration, 16-second
intertrain interval, 4000 pulse-per-session (pps) treat-
ments on the left dorsolateral prefrontal cortex (DLPFC),
followed by slow-frequency (1 Hz), 300-second train dura-
tion, 60-second intertrain interval, 900-pps treatments
on the right DLPFC. Treatments were delivered using a
Mag Pro R30 simulator (Tonica Electronik A/S, Farum,
Denmark) with a cool-B65 figure-of-eight coil at 120% of
the observed motor threshold.
Altogether, the patient received 30 rTMS treatments
over 6 weeks, followed by maintenance treatments every
other week until delivery, for a total of 41 sessions. She
tolerated rTMS extremely well and did not have any side
effects or emergent manic symptoms. The patient repor-
ted resolution of suicidal ideations, marked improvement
Figure 1 Edinburgh Postnatal Depression Scale (EPDS) scores over time.Scores 0-9 normal, 10-30 possible depression.
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in depressive symptoms (particularly dysphoria and aner-
gia), and improved overall daily functioning. The progres-
sive decline in her Edinburgh Postnatal Depression Scale
(EPDS) scores over the course of treatment can be seen
in Figure 1. The patient delivered a healthy full-term infant,
was symptomatically stable postpartum, and reported sustai-
ned improvement of depression on a follow-up phone
call 6 weeks post-delivery.
To our knowledge, this is the first documented report of
rTMS as a potential treatment option in peripartum bipolar
depression. Women with bipolar disorder are at high risk
for peripartum relapse and associated morbidity.2 Effec-
tive treatment is critical, but clinicians must consider the
risks of pharmacotherapy to both the mother and fetus.
This case highlights the usefulness and tolerability of
rTMS as a potential treatment for women with mode-
rate peripartum bipolar depression. Equally importantly,
it illustrates the importance of working with patients in
a collaborative fashion to weigh the risks and benefits
of treatment interventions, including maintaining auton-
omy to decline ECT.
Because rTMS does not involve transplacental pas-
sage, it poses a significant advantage over pharmacolo-
gical treatment. Likewise, rTMS may be advantageous
over ECT because it does not involve the use of anesthe-
tics or intubation, which may be associated with maternal
and neonatal complications.5 Nevertheless, with cur-
rent evidence, the role of rTMS in patients with severe
depression or active suicidality – where ECT would nor-
mally serve as first-line treatment – is still unclear.
Although this case adds to the documentation of safety
and tolerability of rTMS during pregnancy for both
mother and baby, extensive research is still needed to
fully elucidate the role of rTMS treatment in this unique
patient population.
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